Insights from 2024 WCLC


 

WCLC 2024 Insights: Effect of De Novo Co-Mutations on Clinical Outcomes in Patients Receiving 1L Osimertinib for EGFRm mNSCLC

27 views
September 18, 2024
Comments 0
Login to view comments. Click here to Login